Ranstam Review DataBase (RR.db)

References in category "endpoints"

  1. Evans S. When and How Can Endpoints Be Changed after Initiation of a Randomized Clinical Trial? PLoS Clin Trials. 2007;2:e18. [PubMed] [Google]

  2. Ramagopalan S, Skingsley AP, Handunnetthi L, Klingel M, Magnus D, Pakpoor J, Goldacre B. Prevalence of primary outcome changes in clinical trials registered on ClinicalTrials.gov: a cross-sectional study. F1000Research 2014,3:77. [PubMed] [Google]

  3. Serpas VJ, Raghav KP, Halperin DM, Yao J, Overman MJ. Discrepancies in endpoints between clinical trial protocols and clinical trial registration in randomized trials in oncology. BMC Medical Research Methodology 2018;18:169 [PubMed] [Google]

  4. Vera-Badillo FE, Shapiro R, Ocana E, Tannock IF. Bias in reporting of end points of efficacy and toxicity in randomized, clinical trials for women with breast cancer. Ann Oncol 2013 DOI: 10.1093/annonc/mds636. [PubMed] [Google]


[Return]